Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine for pain management in cardiac surgery
ChiCTR2300075287Phase 4Not yet recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Sep 2023
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of liposomal bupivacaine and bupivacaine in postoperative pain (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoint: Cumulative morphine milligram equivalent at 72 hours after surgery. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300075287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075287.